Manojlovic Nebojsa S,Manojlovic Stevan (2026) Letter to the Editor: Rethinking Helicobacter pylori-associated gastroduodenal disease through a systemic immune lens, WORLD JOURNAL OF GASTROINTESTINAL ENDOSCOPY, vol. 18, br. 5, str. - (Letter) 

Manojlovic Nebojsa S,Tufegdzic Ivana Z,Ristanovic Elizabeta S,Rancic Nemanja K,Manojlovic Stevan (2026) Systemic IgG/IgA Balance and Antigen-Specific Seroreactivity as Predictors of the Topographic Distribution of Helicobacter pylori-Associated Gastritis, GASTROINTESTINAL DISORDERS, vol. 8, br. 1, str. - (Article) 

Manojlovic Nebojsa S,Savic Goran,Manojlovic Stevan (2024) Neoadjuvant treatment of pancreatic ductal adenocarcinoma: Whom, when and how, WORLD JOURNAL OF GASTROINTESTINAL SURGERY, vol. 16, br. 5, str. - (Editorial Material) 

Manojlovic Nebojsa S,Tufegdzic Ivana Z,Ristanovic Elizabeta S,Bokonjic Dubravko R (2022) Seroreactivity against Helicobacter pylori VacA, 50 kDa, and 30 kDa along with alarm features may improve the diagnostic approach to uninvestigated dyspepsia - a pilot study, VOJNOSANITETSKI PREGLED, vol. 79, br. 5, str. 448-455 (Article) 

Manojlovic Nebojsa S,Tufegdzic Ivana Z,Ristanovic Elizabeta S,Bokonjic Dubravko R (2022) Simultaneous and alternative IgG seroreactivity against Helicobacter pylori antigens VacA, 30 kDa and 50 kDa is a better biomarker approach for the outcome of infection than VacA and 50 kDa alone, VOJNOSANITETSKI PREGLED, vol. 79, br. 2, str. 133-141 (Article) 

Manojlovic Nebojsa S,Savic Goran,Nikolic Bojan,Rancic Nemanja K (2022) Dynamic monitoring of carcinoembryonic antigen, CA19-9 and inflammation-based indices in patients with advanced colorectal cancer undergoing chemotherapy, WORLD JOURNAL OF CLINICAL CASES, vol. 10, br. 3, str. 899-918 (Article) 

Stemmer Salomon M,Manojlovic Nebojsa S,...,Natosevic Sladjana,...,(broj koautora 21) (2021) Namodenoson in Advanced Hepatocellular Carcinoma and Child-Pugh B Cirrhosis: Randomized Placebo-Controlled Clinical Trial, CANCERS, vol. 13, br. 2, str. - (Article) 

Petrovic Stanko S,Vasiljevska Milijana M,Obradovic Slobodan D,Tarabar Dino K,Doder Radoje,Majstorovic Ivana J,Petrovic Marijana,Magic Zvonko M,Cikota-Aleksic Bojana M,Perisic Nenad,Brcerevic Irina A,Manojlovic Nebojsa S,Rancic Nemanja K (2020) Antiplatelet agents'-ticagrelol and eptifibatide-safety in experimental colitis in mice, TURKISH JOURNAL OF GASTROENTEROLOGY, vol. 31, br. 6, str. 451-458 (Article) 

Manojlovic Nebojsa S,Tufegdzic Ivana Z,Ristanovic Elizabeta S,Bokonjic Dubravko R (2020) Serum IgG antibodies against Helicobacter pylori low molecular weight antigens 50kDa, 30kDa and Urease A 26 kDa, along with vacuolating cytotoxin A are associated with the outcome of the infection, VOJNOSANITETSKI PREGLED, vol. 77, br. 4, str. 405-412 (Article) 

Stemmer Salomon M,Manojlovic Nebojsa S,...,Natosevic Sladjana,...,(broj koautora 20) (2019) A phase II, randomized, double-blind, placebo-controlled trial evaluating efficacy and safety of namodenoson (CF102), an A(3) adenosine receptor agonist (A(3)AR), as a second-line treatment in patients with Child-Pugh B (CPB) advanced hepatocellular carcinoma (HCC)., JOURNAL OF CLINICAL ONCOLOGY, vol. 37, br. 15, str. - (Meeting Abstract) 

Van Cutsem Eric,Hidalgo Manuel,Canon Jean-Luc,Macarulla Teresa,Bazin Igor,Poddubskaya Elena,Manojlovic Nebojsa S,Radenkovic Dejan V,Verslype Chris,Eric Raymond,Cubillo Antonio,Schueler Armin,Zhao Charles,Hammel Pascal (2018) Phase I/II trial of pimasertib plus gemcitabine in patients with metastatic pancreatic cancer, INTERNATIONAL JOURNAL OF CANCER, vol. 143, br. 8, str. 2053-2064 (Article) 

Kim Tae Won,Elme Anneli,Park Joon Oh,Udrea Anghel Adrian,Kim Sun Young,Ahn Joong Bae,Valencia Ricardo Villalobos,Krishnan Srinivasan,Manojlovic Nebojsa S,Guan Xuesong,Lofton-Day Catherine,Jung A Scott,Vrdoljak Eduard (2018) Final Analysis of Outcomes and RAS/BRAF Status in a Randomized Phase 3 Study of Panitumumab and Best Supportive Care in Chemorefractory Wild Type KRAS Metastatic Colorectal Cancer, CLINICAL COLORECTAL CANCER, vol. 17, br. 3, str. 206-214 (Article) 

Glimelius Bengt,Manojlovic Nebojsa S,Pfeiffer Per,Mosidze Baadur,Kurteva Galina,Karlberg Mia,Mahalingam Devalingam,Buhl Jensen Peter,Kowalski Jan,Bengtson Marie,Nittve Malin,Nasstrom Jacques (2018) Persistent prevention of oxaliplatin-induced peripheral neuropathy using calmangafodipir (PledOx((R))): a placebo-controlled randomised phase II study (PLIANT), ACTA ONCOLOGICA, vol. 57, br. 3, str. 393-402 (Article) 

Glimelius Bengt,Manojlovic Nebojsa S,Pfeiffer Per,Mosidze Baadur,Petrova-Kurteva Galina,Karlberg Mia,Mahalingam Devalingam,Bengtson Marie,Nasstrom Jacques (2016) Persistent prevention of CIPN using calmangafodipir (Pled Ox): Results from a placebo-controlled randomized phase II study (PLIANT) in patients with metastatic colorectal cancer (mCRC)., JOURNAL OF CLINICAL ONCOLOGY, vol. 34, br. 15, str. - (Meeting Abstract) 

Vrdoljak Eduard,...,Kusic Zvonko,...,Manojlovic Nebojsa S,...,(broj koautora 16) (2016) Association of ECOG performance status with efficacy in patients receiving panitumumab with best supportive care (BSC) vs BSC alone for chemorefractory metastatic colorectal cancer, JOURNAL OF CLINICAL ONCOLOGY, vol. 34, br. 15, str. - (Meeting Abstract) 

Kim Tae Won,...,Kusic Zvonko,...,Manojlovic Nebojsa S,...,(broj koautora 16) (2016) Final results from a phase III trial evaluating panitumumab (pmab) plus best supportive care (BSC) vs BSC in chemorefractory wild-type (WT) KRAS exon 2 and WT RAS metastatic colorectal cancer (mCRC)., JOURNAL OF CLINICAL ONCOLOGY, vol. 34, br. 15, str. - (Meeting Abstract) 

Kim Tae Won,...,Manojlovic Nebojsa S,...,(broj koautora 16) (2016) A phase 3 trial evaluating panitumumab plus best supportive care vs best supportive care in chemorefractory wild-type KRAS or RAS metastatic colorectal cancer, BRITISH JOURNAL OF CANCER, vol. 115, br. 10, str. 1206-1214 (Article) 

Van Cutsem Eric,Hidalgo Manuel,Bazin Igor,Canon Jean-Luc,Poddubskaya Elena,Manojlovic Nebojsa S,Milella Michele,Radenkovic Dejan V,Verslype Chris,Guo Wei,Damstrup Lars,Hammel Pascal (2015) Phase II randomized trial of MEK inhibitor pimasertib or placebo combined with gemcitabine in the first-line treatment of metastatic pancreatic cancer., JOURNAL OF CLINICAL ONCOLOGY, vol. 33, br. 3, str. - (Meeting Abstract) 

Palibrk Ivan G,Milicic Biljana R,Stojiljkovic Ljuba,Manojlovic Nebojsa S,Dugalic Vladimir D,Bumbasirevic Vesna D,Kalezic Nevena K,Zuvela Marinko M,Milicevic Miroslav N (2012) Clamp-Crushing vs. Radiofrequency-Assisted Liver Resection: Changes in Liver Function Tests, HEPATO-GASTROENTEROLOGY, vol. 59, br. 115, str. 800-804 (Article) 

Kovcin Vladimir N,Manojlovic Nebojsa S,Jovanovic Dusan,Vrbic Svetislav,Andric Zoran G,Nikolic Ivan V,Pantelic Aleksandra,Ursulovic Tamara B (2011) The Impact of Capecitabine Dose Modification to Duration of Treatment in Patients with Metastatic Colorectal Cancer - First Results From Axiom Trial, ANNALS OF ONCOLOGY, vol. 22, br. , str. v101-v102 (Meeting Abstract) 

Kovcin Vladimir N,Jovanovic Dusan,Manojlovic Nebojsa S,Vrbic Svetislav,Andric Zoran G,Nikolic Ivan V,Pantelic Aleksandra,Radosavljevic Davorin Z (2011) Prospective Evaluation of Response and Conversion-to-resectability Rate in Patients with Metastatic Colorectal Cancer After 4 Cycles Capox/folfox Plus Bevacizumab - Updated Results From Relevant Trial, ANNALS OF ONCOLOGY, vol. 22, br. , str. v101-v101 (Meeting Abstract) 

Radic S,Markovic M,Kovcin Vladimir N,Andric Zoran G,Manojlovic Nebojsa S,Jovanovic Dusan,Nikolic Ivan V,Pantelic Aleksandra,Popov Ivan P (2010) Relevant: Prospective Evaluation of Efficacy and Safety of Bevacizumab Therapy in Metastatic Colorectal Carcinoma; Interim Analysis of Resecatability Rate, ANNALS OF ONCOLOGY, vol. 21, br. , str. 217-217 (Meeting Abstract) 

Manojlovic Nebojsa S,Babic Dragana,Stojanovic Snezana,Filipovic Ivana,Doder Radoje (2008) Capecitabine cardiotoxicity - Case reports and literature review, HEPATO-GASTROENTEROLOGY, vol. 55, br. 85, str. 1249-1256 (Review) 

Manojlovic Nebojsa S,Babic Dragana,Filipovic-Ljeskovic Ivana M,Pilcevic Dijana R (2008) Anti Helicobacter pylori IgG and IgA response in patients with gastric cancer and chronic gastritis, HEPATO-GASTROENTEROLOGY, vol. 55, br. 82-83, str. 807-813 (Article) 

Manojlovic Nebojsa S,Babic Dragana (2004) Radiation-induced rectal ulcer - Prognostic factors and medical treatment, HEPATO-GASTROENTEROLOGY, vol. 51, br. 56, str. 447-450 (Article) 

Manojlovic Nebojsa S,Nikolic M,Pilcevic Dijana R,Josifovski Jeremija J,Babic Dragana (2004) Systemic humoral anti-Helicobacter pylori immune response in patients with gastric malignancies and benign gastroduodenal disease, HEPATO-GASTROENTEROLOGY, vol. 51, br. 55, str. 282-284 (Article) 

Manojlovic Nebojsa S,Babic Dragana,Filipovic-Ljeskovic Ivana M,Pilcevic Dijana R (2002) Anti Helicobacter pylori immune response in patients with gastric cancer, gastric lymphoma, gastritis and duodenal ulcer, GUT, vol. 51, br. , str. A57-A57 (Meeting Abstract) 

Manojlovic Nebojsa S,Babic Dragana (2002) Age, sex, primary tumor site and degree of tumor differentiation as prognostic factors in patients with Dukes c stage colon cancer receiving adjuvant treatment, INTERNATIONAL JOURNAL OF CANCER, vol. , br. , str. 229-229 (Meeting Abstract)